Apellis Pharmaceuticals saw the highest growth of 2.32% in patent filings and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.32% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Apellis Pharmaceuticals’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Apellis Pharmaceuticals has been focused on protecting inventions in European Patent Office(EPO) with six publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 36% of filings. The European Patent Office(EPO), Australia(AU), United States(US), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Apellis Pharmaceuticals is filings its patents. Among the top granted patent authorities, Apellis Pharmaceuticals has 33% of its grants in Australia(AU) and 33% in Israel(IL).
Hanmi Science could be the strongest competitor for Apellis Pharmaceuticals
Patents related to genomics and addiction lead Apellis Pharmaceuticals's portfolio
Apellis Pharmaceuticals has the highest number of patents in genomics followed by, addiction and rare diseases. For genomics, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Geographic atrophy related patents lead Apellis Pharmaceuticals portfolio followed by syringe pumps, and acquired (autoimmune) hemolytic anemia
Apellis Pharmaceuticals has highest number of patents in geographic atrophy followed by syringe pumps, acquired (autoimmune) hemolytic anemia, idiopathic pulmonary fibrosis, and chronic obstructive pulmonary disease (copd).
For comprehensive analysis of Apellis Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
